Her‐2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab‐based therapy in patients with metastatic breast cancer
暂无分享,去创建一个
J. Attems | E. Kubista | C. Singer | D. Gschwantler-Kaulich | C. Zielinski | W. Köstler | G. Hudelist | M. Manavi | K. Czerwenka | R. Müller | H. Hoschützky | Isabell Huber | Wolfgang J. Köstler